Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors-Reference-Cited by-同舟云学术

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors

Published:2008-05-08 Issue:9 Volume:34 Page:1638-1645
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Cantaluppi Vincenzo,Assenzio Barbara,Pasero Daniela,Romanazzi Giuseppe Mauriello,Pacitti Alfonso,Lanfranco Giacomo,Puntorieri Valeria,Martin Erica L.,Mascia Luciana,Monti Gianpaola,Casella Giampaolo,Segoloni Giuseppe Paolo,Camussi Giovanni,Ranieri V. Marco

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00134-008-1124-6.pdf

Reference38 articles.

1. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169

2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310

3. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172:2629–2635

4. Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY, Won NH (2002) Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 91:406–415

5. Guo R, Wang Y, Minto AW, Quigg RJ, Cunningham PN (2004) Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 15:3093–3102

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-volume hemofiltration does not protect human kidney endothelial and tubular epithelial cells from septic plasma-induced injury;Scientific Reports;2024-08-07

2. The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis;Heliyon;2024-07

3. Improving Survival in Sepsis: Optimizing Treatment Duration with Polymyxin-B Immobilized Hemoperfusion—A Comprehensive Network Meta-Analysis;2024-05-13

4. Clinical implications of endotoxin activity and Polymyxin‐B hemoperfusion in critically ill patients with septic cardiomyopathy: A single‐center, retrospective, observational study;Artificial Organs;2023-09-22

5. Blood Purification for Adult Patients With Severe Infection or Sepsis/Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials;Critical Care Medicine;2023-07-20